278 related articles for article (PubMed ID: 31209784)
1. Influence of Matrix Metallopeptidase 9 on Beta-Amyloid Elimination Across the Blood-Brain Barrier.
Shackleton B; Ringland C; Abdullah L; Mullan M; Crawford F; Bachmeier C
Mol Neurobiol; 2019 Dec; 56(12):8296-8305. PubMed ID: 31209784
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E isoform-specific effects on lipoprotein receptor processing.
Bachmeier C; Shackleton B; Ojo J; Paris D; Mullan M; Crawford F
Neuromolecular Med; 2014 Dec; 16(4):686-96. PubMed ID: 25015123
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
Shackleton B; Crawford F; Bachmeier C
Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E isoforms differentially regulate matrix metallopeptidase 9 function in Alzheimer's disease.
Ringland C; Schweig JE; Paris D; Shackleton B; Lynch CE; Eisenbaum M; Mullan M; Crawford F; Abdullah L; Bachmeier C
Neurobiol Aging; 2020 Nov; 95():56-68. PubMed ID: 32758917
[TBL] [Abstract][Full Text] [Related]
5. A multifaceted role for apoE in the clearance of beta-amyloid across the blood-brain barrier.
Bachmeier C; Paris D; Beaulieu-Abdelahad D; Mouzon B; Mullan M; Crawford F
Neurodegener Dis; 2013; 11(1):13-21. PubMed ID: 22572854
[TBL] [Abstract][Full Text] [Related]
6. Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism.
Ma Q; Zhao Z; Sagare AP; Wu Y; Wang M; Owens NC; Verghese PB; Herz J; Holtzman DM; Zlokovic BV
Mol Neurodegener; 2018 Oct; 13(1):57. PubMed ID: 30340601
[TBL] [Abstract][Full Text] [Related]
7. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain.
Deane R; Sagare A; Hamm K; Parisi M; Lane S; Finn MB; Holtzman DM; Zlokovic BV
J Clin Invest; 2008 Dec; 118(12):4002-13. PubMed ID: 19033669
[TBL] [Abstract][Full Text] [Related]
8. MMP9 modulation improves specific neurobehavioral deficits in a mouse model of Alzheimer's disease.
Ringland C; Schweig JE; Eisenbaum M; Paris D; Ait-Ghezala G; Mullan M; Crawford F; Abdullah L; Bachmeier C
BMC Neurosci; 2021 May; 22(1):39. PubMed ID: 34034683
[TBL] [Abstract][Full Text] [Related]
9. Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system.
Bell RD; Sagare AP; Friedman AE; Bedi GS; Holtzman DM; Deane R; Zlokovic BV
J Cereb Blood Flow Metab; 2007 May; 27(5):909-18. PubMed ID: 17077814
[TBL] [Abstract][Full Text] [Related]
10. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice.
Hu J; Liu CC; Chen XF; Zhang YW; Xu H; Bu G
Mol Neurodegener; 2015 Mar; 10():6. PubMed ID: 25871773
[TBL] [Abstract][Full Text] [Related]
11. ApoE-isoform-dependent cellular uptake of amyloid-β is mediated by lipoprotein receptor LR11/SorLA.
Yajima R; Tokutake T; Koyama A; Kasuga K; Tezuka T; Nishizawa M; Ikeuchi T
Biochem Biophys Res Commun; 2015 Jan; 456(1):482-8. PubMed ID: 25482438
[TBL] [Abstract][Full Text] [Related]
12. Chronic cerebral hypoperfusion-induced impairment of Aβ clearance requires HB-EGF-dependent sequential activation of HIF1α and MMP9.
Ashok A; Rai NK; Raza W; Pandey R; Bandyopadhyay S
Neurobiol Dis; 2016 Nov; 95():179-93. PubMed ID: 27431094
[TBL] [Abstract][Full Text] [Related]
13. Role of the cannabinoid system in the transit of beta-amyloid across the blood-brain barrier.
Bachmeier C; Beaulieu-Abdelahad D; Mullan M; Paris D
Mol Cell Neurosci; 2013 Sep; 56():255-62. PubMed ID: 23831388
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E increases cell association of amyloid-β 40 through heparan sulfate and LRP1 dependent pathways.
O'Callaghan P; Noborn F; Sehlin D; Li JP; Lannfelt L; Lindahl U; Zhang X
Amyloid; 2014 Jun; 21(2):76-87. PubMed ID: 24491019
[TBL] [Abstract][Full Text] [Related]
15. Macrophage-mediated degradation of beta-amyloid via an apolipoprotein E isoform-dependent mechanism.
Zhao L; Lin S; Bales KR; Gelfanova V; Koger D; Delong C; Hale J; Liu F; Hunter JM; Paul SM
J Neurosci; 2009 Mar; 29(11):3603-12. PubMed ID: 19295164
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of the retinoid X receptor facilitates beta-amyloid clearance across the blood-brain barrier.
Bachmeier C; Beaulieu-Abdelahad D; Crawford F; Mullan M; Paris D
J Mol Neurosci; 2013 Feb; 49(2):270-6. PubMed ID: 22890420
[TBL] [Abstract][Full Text] [Related]
17. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.
Keeney JT; Ibrahimi S; Zhao L
J Alzheimers Dis; 2015; 48(2):411-24. PubMed ID: 26402005
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease.
Donahue JE; Johanson CE
J Neuropathol Exp Neurol; 2008 Apr; 67(4):261-70. PubMed ID: 18379441
[TBL] [Abstract][Full Text] [Related]
19. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
Aleshkov S; Abraham CR; Zannis VI
Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639
[TBL] [Abstract][Full Text] [Related]
20. Endothelial LRP1 transports amyloid-β(1-42) across the blood-brain barrier.
Storck SE; Meister S; Nahrath J; Meißner JN; Schubert N; Di Spiezio A; Baches S; Vandenbroucke RE; Bouter Y; Prikulis I; Korth C; Weggen S; Heimann A; Schwaninger M; Bayer TA; Pietrzik CU
J Clin Invest; 2016 Jan; 126(1):123-36. PubMed ID: 26619118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]